NorthCoast Asset Management’s GSK GSK Stock Holding History

NorthCoast Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-38,362	Closed	-$1.92M	–	244
2019 Q2	$1.92M	Sell	38,362 -167	-0.4%	-$8.38K	0.12%	110
2019 Q1	$2.01M	Sell	38,529 -423	-1%	-$21.1K	0.13%	101
2018 Q4	$1.86M	Buy	+38,952	New	+$1.92M	0.14%	95
2017 Q4	–	Sell	-95,860	Closed	-$4.87M	–	185
2017 Q3	$4.87M	Buy	95,860 +50,553	+112%	+$2.56M	0.57%	36
2017 Q2	$2.44M	Buy	+45,307	New	+$2.42M	0.28%	65
2017 Q1	–	Sell	-22,342	Closed	-$1.07M	–	186
2016 Q4	$1.07M	Sell	22,342 -3,896	-15%	-$192K	0.11%	127
2016 Q3	$1.42M	Buy	+26,238	New	+$1.44M	0.12%	107
2014 Q2	–	Sell	-39,094	Closed	-$2.61M	–	174
2014 Q1	$2.61M	Buy	39,094 +3,446	+10%	+$233K	0.17%	74
2013 Q4	$2.38M	Buy	35,648 +11,652	+49%	+$756K	0.15%	67
2013 Q3	$1.5M	Buy	+23,996	New	+$1.54M	0.1%	78

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

NorthCoast Asset Management's GSK Position: Q3 2019 in Review

NorthCoast Asset Management sold out of GSK (GSK) in Q3 2019, closing a stake of 38,362 shares — an estimated $1.92M sold.

NorthCoast Asset Management first reported a position in GSK in Q3 2013 and held it in 10 quarters. The position peaked at $4.87M in Q3 2017. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

NorthCoast Asset Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
NorthCoast Asset Management sold 38,362 GSK shares in Q3 2019, an estimated $1.92M.
NorthCoast Asset Management first reported a position in GSK in Q3 2013 and held it in 10 quarters.
NorthCoast Asset Management's GSK position peaked at $4.87M in Q3 2017.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on NorthCoast Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.